FI92197B - Substituerade 1,2,3-tiadiazol-4-tiolater - Google Patents
Substituerade 1,2,3-tiadiazol-4-tiolater Download PDFInfo
- Publication number
- FI92197B FI92197B FI873000A FI873000A FI92197B FI 92197 B FI92197 B FI 92197B FI 873000 A FI873000 A FI 873000A FI 873000 A FI873000 A FI 873000A FI 92197 B FI92197 B FI 92197B
- Authority
- FI
- Finland
- Prior art keywords
- give
- ether
- vacuo
- dichloromethane
- concentrated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/58—Derivatives of thiocarboxylic acids, the doubly-bound oxygen atoms being replaced by nitrogen atoms, e.g. imino-thio ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Lubricants (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Catalysts (AREA)
- Saccharide Compounds (AREA)
Claims (10)
1. Förening, kännetecknad därav, att den har formeln
5 SCH2CH2COOR4 N-/ \Γ\ 10. vilken R, är väte, C^-alkyl, fenyl, substituerad fenyl, vars substituenter är C,.6-alkyl, C^-alkoxi, klor, fluor och/eller trifluorinetyl, naftyl, tienyl, fenyltio, tetra-hydropyranyl, bensyl eller -COOC2H5, och R4 är C,_3-alkyl.
2. Förening, kännetecknad därav, att 15 den har formeln S® M© N-/ "'jXi 20 i vilken R, är väte, Cj_6-alkyl, fenyl, substituerad fenyl, vars substituenter är C,.6-alkyl, C1.3-alkoxi, klor, fluor och/eller trifluormetyl, naftyl, tienyl, fenyltio, tetra-hydropyranyl, bensyl eller -COOC2H5, och M är natrium eller 25 kalium.
3. Förening enligt patentkrav 2, kännetecknad därav, att den är ett natriumsalt av 1,2,3-tiadiazol-4-tiol.
4. Förening enligt patentkrav 2, kanne- 30 tecknad därav, att den är ett natriumsalt av 5-me-tyl-1,2,3-tiadiazol-4-tiol.
5. Förening enligt patentkrav 2, kännetecknad därav, att den är ett natriumsalt av 5-etyl-1,2,3-tiadiazol-4-tiol. 92197
6. Förening enligt patentkrav 2, känne- t e c k n a d därav, att den är ett natriumsalt av 5-(1,l-dimetyletyl)-1,2,3-tiadiazol-4-tiol.
7. Förening enligt patentkrav 2, k ä n n e - 5 tecknad därav, att den är ett kaliumsalt av 5-fe-nyl-1,2,3-tiadiazol-4-tiol.
8. Förening enligt patentkrav 2, känne-tecknad därav, att den är ett kaliumsalt 5-(4-me-tylfenyl)-1,2,3-tiadiazol-4-tiol. 10 9. Förening enligt patentkrav 2, känne- tecknad därav, att den är ett kaliumsalt av 5-[4-(1,l-dimetyletyl)fenyl]-l,2,3-tiadiazol-4-tiol.
10. Förening enligt patentkrav 2, känne-tecknad därav, att den är ett natriumsalt av 5-[3-15 (trifluormetyl)fenyl]-l,2,3-tiadiazol-4-tiol. »
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI923615A FI91854C (sv) | 1986-07-08 | 1992-08-12 | Substituerade N3-tioasylsemikarbatsider |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/883,189 US4803280A (en) | 1986-07-08 | 1986-07-08 | Substituted 1,2,3-thia-diazole-4-thiolates |
| US88318986 | 1986-07-08 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI873000A0 FI873000A0 (sv) | 1987-07-07 |
| FI873000A FI873000A (sv) | 1988-01-09 |
| FI92197B true FI92197B (sv) | 1994-06-30 |
| FI92197C FI92197C (sv) | 1994-10-10 |
Family
ID=25382143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI873000A FI92197C (sv) | 1986-07-08 | 1987-07-07 | Substituerade 1,2,3-tiadiazol-4-tiolater |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4803280A (sv) |
| EP (2) | EP0525832A1 (sv) |
| JP (2) | JPH0774192B2 (sv) |
| KR (1) | KR950004049B1 (sv) |
| AT (1) | ATE88464T1 (sv) |
| AU (1) | AU596197B2 (sv) |
| CA (1) | CA1326488C (sv) |
| DE (1) | DE3785498T2 (sv) |
| DK (2) | DK349787A (sv) |
| ES (1) | ES2053474T3 (sv) |
| FI (1) | FI92197C (sv) |
| GR (1) | GR3007684T3 (sv) |
| HU (1) | HU201918B (sv) |
| IE (1) | IE60261B1 (sv) |
| IL (1) | IL83118A (sv) |
| NO (1) | NO169898C (sv) |
| NZ (1) | NZ220996A (sv) |
| PH (3) | PH23917A (sv) |
| PT (1) | PT85275B (sv) |
| ZA (1) | ZA874942B (sv) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH556862A (en) * | 1970-01-15 | 1974-12-13 | Air Prod & Chem | 1-(1,3,4-Thiadiazol-2-yl)-urea derivs as herbicides - and fungicides, prepd. from 2-amino-1,3,4-thiadiazoles |
| DE2856404A1 (de) * | 1978-12-28 | 1980-07-17 | Dynamit Nobel Ag | 1,2,3-thiadiazol-5-yl-thioglycolsaeure, deren derivate sowie verfahren zu deren herstellung |
| EP0252473A3 (en) * | 1986-07-08 | 1989-07-05 | American Cyanamid Company | 7 beta-(substituted) amino-3-substituted cephalosporanic acids and esters |
-
1986
- 1986-07-08 US US06/883,189 patent/US4803280A/en not_active Expired - Fee Related
-
1987
- 1987-07-06 EP EP92117416A patent/EP0525832A1/en not_active Ceased
- 1987-07-06 EP EP87109703A patent/EP0252474B1/en not_active Expired - Lifetime
- 1987-07-06 ES ES87109703T patent/ES2053474T3/es not_active Expired - Lifetime
- 1987-07-06 AT AT87109703T patent/ATE88464T1/de not_active IP Right Cessation
- 1987-07-06 DE DE87109703T patent/DE3785498T2/de not_active Expired - Fee Related
- 1987-07-07 NO NO872824A patent/NO169898C/no unknown
- 1987-07-07 IE IE180587A patent/IE60261B1/en not_active IP Right Cessation
- 1987-07-07 FI FI873000A patent/FI92197C/sv not_active IP Right Cessation
- 1987-07-07 PT PT85275A patent/PT85275B/pt not_active IP Right Cessation
- 1987-07-07 ZA ZA874942A patent/ZA874942B/xx unknown
- 1987-07-07 DK DK349787A patent/DK349787A/da not_active Application Discontinuation
- 1987-07-07 AU AU75312/87A patent/AU596197B2/en not_active Ceased
- 1987-07-08 JP JP62170844A patent/JPH0774192B2/ja not_active Expired - Lifetime
- 1987-07-08 PH PH35513A patent/PH23917A/en unknown
- 1987-07-08 HU HU873078A patent/HU201918B/hu not_active IP Right Cessation
- 1987-07-08 NZ NZ220996A patent/NZ220996A/xx unknown
- 1987-07-08 CA CA000541592A patent/CA1326488C/en not_active Expired - Fee Related
- 1987-07-08 IL IL83118A patent/IL83118A/xx not_active IP Right Cessation
- 1987-07-08 KR KR1019870007353A patent/KR950004049B1/ko active IP Right Grant
-
1988
- 1988-09-21 PH PH37573A patent/PH24927A/en unknown
- 1988-09-21 PH PH37572A patent/PH24971A/en unknown
-
1993
- 1993-04-22 GR GR920402984T patent/GR3007684T3/el unknown
- 1993-05-05 DK DK93518A patent/DK51893D0/da unknown
-
1995
- 1995-02-02 JP JP7035896A patent/JPH07324067A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5204361B2 (ja) | １，５−ベンゾチアゼピンと脂質低下薬としてのその使用 | |
| CS399991A3 (en) | Amide derivatives | |
| AU2007272683B2 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
| CZ192297A3 (en) | Substituted azetidin-2-ones for treating atherosclerosis, process of their preparation and use | |
| WO1998043963A1 (en) | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses | |
| AU2008208042B2 (en) | Substituted arylcyclopentenes as therapeutic agents | |
| AU6263794A (en) | Carbostyril derivatives as matrix metalloproteinases inhibitors | |
| US5594006A (en) | Carbostyril derivatives as matrix metalloproteinases inhibitors | |
| FI92197B (sv) | Substituerade 1,2,3-tiadiazol-4-tiolater | |
| US5106860A (en) | Thiazolidin-4-one derivatives and acid addition salts thereof useful for treating paf mediated diseases | |
| EP0421365B1 (en) | Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity | |
| FR2485016A1 (fr) | Derives d'acide phosphonique de ((amino-2 thiazolyl-4) oximino)-7 cephalosporines, utiles notamment comme medicaments antibacteriens | |
| FI91854B (sv) | Substituerade N3-tioasylsemikarbatsider | |
| CA2471814C (en) | Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient | |
| US4916237A (en) | Substituted 1,2,3-thiadiazole-4-thiolates | |
| KR0152666B1 (ko) | 벤조-1,2,3-티아디아졸 유도체 및 그의 제조방법 | |
| SK280929B6 (sk) | Substituované 3-metylén-2-oxindol-1-karboxamidy, ich použitie a farmaceutické prostriedky na ich báze | |
| US4500709A (en) | Thiinyl and oxothiolyl derivatives | |
| JPH0881443A (ja) | 細胞外マトリックス金属プロテアーゼ阻害剤 | |
| US4242510A (en) | Cephalosporin compounds and processes for the preparation thereof | |
| PT1735297E (pt) | Processo de síntese e intermediários de benzoxatiepinas | |
| KR100372757B1 (ko) | 메트릭스 메탈로프로테이나제의 저해제로서의 설폰아미드유도체 | |
| FR2573428A1 (fr) | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent | |
| JPH07157470A (ja) | カルボスチリル誘導体 | |
| FR2551750A1 (fr) | 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: AMERICAN CYANAMID COMPANY |